Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Ilex and Millennium respond to FDA letter on Campath

Aug. 24, 2000

Bioniche reports preclinical findings for MCC in prostate cancer

Aug. 21, 2000

Phytera and Novelos Therapeutics enter collaborative agreement for novel cancer immunotherapy

Aug. 18, 2000

Biomira initiates phase IIb trial of BLP25 vaccine

Aug. 11, 2000

Positive interim phase I/II data shown for Multikine in head and neck cancer

Aug. 9, 2000

Allovectin-7 phase I/II data released

Aug. 8, 2000

Beta LT meets safety goals early in clinical trials

Aug. 7, 2000

Trial set to test efficacy of bismuth-213-labeled monoclonal antibody in leukemia patients

Aug. 4, 2000

SciClone's Zadaxin prevents lung tumors in mouse model

Aug. 4, 2000

Clinicians urge review of the cardiotoxicity of trastuzumab

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...